(BRNL) Brunel International - Ratings and Ratios
Recruitment,Consultancy,ProjectManagement,WorkforceSolutions,GlobalMobility
Description: BRNL Brunel International
Brunel International NV is a global provider of human resource and employment services, operating in multiple regions including Europe, Australasia, the Middle East, India, Asia, and the Americas. The company offers a range of services including project management, recruitment, consultancy, and global mobility solutions to various industries such as life sciences, renewable energy, and infrastructure.
The companys services can be categorized into three main areas: project and consulting solutions, workforce solutions, and global mobility solutions. This diversified service portfolio allows Brunel to cater to the complex needs of its clients across different sectors and geographies. Key performance indicators (KPIs) that could be relevant for evaluating Brunels performance include revenue growth, gross margin, and client acquisition rates.
From a financial perspective, Brunel International NV has a market capitalization of approximately 449.47 million EUR, with a price-to-earnings ratio of 15.14 and a forward P/E of 14.60. The companys return on equity (RoE) stands at 18.24%, indicating a relatively strong profitability. Other relevant KPIs could include revenue per employee, employee retention rates, and the ratio of contract to permanent placements.
To further analyze Brunels stock, one could examine its technical indicators, such as the moving averages and average true range. While the stocks current price is 9.16, it has shown a relatively stable trend with its 20-day, 50-day, and 200-day moving averages at 9.10, 8.94, and 8.75, respectively. The ATR of 0.18 indicates a moderate level of price volatility.
BRNL Stock Overview
| Market Cap in USD | 477m |
| Sub-Industry | Human Resource & Employment Services |
| IPO / Inception |
BRNL Stock Ratings
| Growth Rating | 1.74% |
| Fundamental | 73.8% |
| Dividend Rating | 82.4% |
| Return 12m vs S&P 500 | -16.8% |
| Analyst Rating | - |
BRNL Dividends
| Dividend Yield 12m | 6.92% |
| Yield on Cost 5y | 10.83% |
| Annual Growth 5y | 22.39% |
| Payout Consistency | 78.2% |
| Payout Ratio | 3.1% |
BRNL Growth Ratios
| Growth Correlation 3m | -83.8% |
| Growth Correlation 12m | -1.5% |
| Growth Correlation 5y | 22.8% |
| CAGR 5y | -0.76% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.02 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.04 |
| Sharpe Ratio 12m | -1.07 |
| Alpha | -16.89 |
| Beta | 0.670 |
| Volatility | 23.70% |
| Current Volume | 60.6k |
| Average Volume 20d | 62.5k |
| Stop Loss | 7.7 (-3.1%) |
| Signal | -0.21 |
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (54.8m TTM) > 0 and > 6% of Revenue (6% = 137.4m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 7.49pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 11.27% (prev 21.29%; Δ -10.02pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.14 (>3.0%) and CFO 74.6m > Net Income 54.8m (YES >=105%, WARN >=100%) |
| Net Debt (12.1m) to EBITDA (143.4m) ratio: 0.08 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.71 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (50.3m) change vs 12m ago -0.14% (target <= -2.0% for YES) |
| Gross Margin 31.16% (prev 38.58%; Δ -7.42pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 396.5% (prev 218.9%; Δ 177.6pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 13.43 (EBITDA TTM 143.4m / Interest Expense TTM 8.24m) >= 6 (WARN >= 3) |
Altman Z'' 4.40
| (A) 0.47 = (Total Current Assets 409.1m - Total Current Liabilities 150.9m) / Total Assets 544.1m |
| (B) 0.00 = Retained Earnings (Balance) 304.0k / Total Assets 544.1m |
| (C) 0.19 = EBIT TTM 110.6m / Avg Total Assets 577.7m |
| (D) 0.00 = Book Value of Equity 304.0k / Total Liabilities 274.1m |
| Total Rating: 4.40 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 73.84
| 1. Piotroski 7.50pt = 2.50 |
| 2. FCF Yield 10.15% = 5.0 |
| 3. FCF Margin 1.49% = 0.37 |
| 4. Debt/Equity data missing |
| 5. Debt/Ebitda 0.08 = 2.49 |
| 6. ROIC - WACC (= 9.47)% = 11.84 |
| 7. RoE 18.52% = 1.54 |
| 8. Rev. Trend 26.29% = 1.97 |
| 9. EPS Trend -37.56% = -1.88 |
What is the price of BRNL shares?
Over the past week, the price has changed by -2.45%, over one month by -3.40%, over three months by -13.87% and over the past year by -3.37%.
Is Brunel International a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BRNL is around 7.18 EUR . This means that BRNL is currently overvalued and has a potential downside of -9.69%.
Is BRNL a buy, sell or hold?
What are the forecasts/targets for the BRNL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.3 | 16.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 8 | 0.8% |
BRNL Fundamental Data Overview
Market Cap EUR = 410.7m (410.7m EUR * 1.0 EUR.EUR)
P/E Trailing = 27.0667
P/E Forward = 14.1443
P/S = 0.3193
P/B = 1.5294
P/EG = 1.99
Beta = 0.67
Revenue TTM = 2.29b EUR
EBIT TTM = 110.6m EUR
EBITDA TTM = 143.4m EUR
Long Term Debt = 87.5m EUR (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = 12.1m EUR (from netDebt column, last quarter)
Enterprise Value = 335.3m EUR (410.7m + (null Debt) - CCE 75.4m)
Interest Coverage Ratio = 13.43 (Ebit TTM 110.6m / Interest Expense TTM 8.24m)
FCF Yield = 10.15% (FCF TTM 34.0m / Enterprise Value 335.3m)
FCF Margin = 1.49% (FCF TTM 34.0m / Revenue TTM 2.29b)
Net Margin = 2.39% (Net Income TTM 54.8m / Revenue TTM 2.29b)
Gross Margin = 31.16% ((Revenue TTM 2.29b - Cost of Revenue TTM 1.58b) / Revenue TTM)
Gross Margin QoQ = 18.68% (prev 100.0%)
Tobins Q-Ratio = 0.62 (Enterprise Value 335.3m / Total Assets 544.1m)
Interest Expense / Debt = unknown (Interest Expense 4.18m / Debt none)
Taxrate = 38.24% (9.69m / 25.3m)
NOPAT = 68.3m (EBIT 110.6m * (1 - 38.24%))
Current Ratio = 2.71 (Total Current Assets 409.1m / Total Current Liabilities 150.9m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = 0.08 (Net Debt 12.1m / EBITDA 143.4m)
Debt / FCF = 0.36 (Net Debt 12.1m / FCF TTM 34.0m)
Total Stockholder Equity = 296.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.07% (Net Income 54.8m / Total Assets 544.1m)
RoE = 18.52% (Net Income TTM 54.8m / Total Stockholder Equity 296.0m)
RoCE = 28.85% (EBIT 110.6m / Capital Employed (Equity 296.0m + L.T.Debt 87.5m))
RoIC = 17.95% (NOPAT 68.3m / Invested Capital 380.7m)
WACC = 8.48% (E(410.7m)/V(410.7m) * Re(8.48%) + (debt-free company))
Discount Rate = 8.48% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 80.04% ; FCFE base≈34.0m ; Y1≈42.0m ; Y5≈71.7m
Fair Price DCF = 22.25 (DCF Value 1.12b / Shares Outstanding 50.3m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -37.56 | EPS CAGR: -58.19% | SUE: 0.0 | # QB: 0
Revenue Correlation: 26.29 | Revenue CAGR: 31.08% | SUE: N/A | # QB: 0